Combination of Diet and Oral Budesonide for Ulcerative Colitis
Recruiting
N/A
Interventional Study
Ulcerative Colitis
Ulcerative Colitis Chronic Mild
Ulcerative Colitis Chronic Moderate
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 17 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Wolfson Medical Center · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ReDUCE Trial is a multinational single-blinded randomized controlled trial in mild to moderate flare of Ulcerative colitis (UC) disease patients. The purpose of the study is to validate the clinical efficacy of the UCED (Ulcerative colitis Exclusion Diet) with partial enteral nutrition (PEN) using a novel formula.
The investigators anticipate that adding a novel specifically designed dietary …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Informed consent
* Established diagnosis of UC with mild to moderate active disease, 5 ≤ SCCAI ≤ 10
* Age: 17-65 years (inclusive)
* Extent E1-E3 by the Montreal classification
* Active colitis in the rectum or sigmoid colon on sigmoidoscopy
* Stable medication use of oral 5AS…
Contacts
No contact information available.